Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R, Basile VS, Beitchman
J e Kennedy JL. 2000. Evidence for the serotonin HTR2A receptor gene as a
susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol Psychiatry
5:537-541.
Rhode LA, Biederman J, Busnello EA, Zimmerman H, Schmitz M, Martins S, Tramontina
S. 1999. ADHD in a school sample of Brazilian adolescents: A study of prevalence,
comorbid conditions and impairments. J Am Aca d Child Adolesc Psychiatry 38:716-
722.
Robichaud M and Debonnel G. 2005. Oestrogen and Testosterone Modulate the Firing
Activity of Dorsal Raphe Nucleus Serotonergic Neurones in Both Male and Female
Rats. J Neuroendoc 17:179-185
Rohde LA. 2002. ADHD in a developing country: are DSM-IV criteria suitable for
culturally different populations? J Am Acad Child Adolesc Psychiatry 41:1131-1133.
Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH. 2001. Attention-
deficit/hyperactivity disorder: A study of association with both the dopamine
transporter gene and the dopamine D4 receptor gene. Am J Med Genet (Neuropsychiatr
Genet) 105:471-478.
Ruotsalainen S, Sirvio J, Jakala P, Puumala T, MacDonald E, Riekkinen P Sr. 1997.
Differential effects of three 5-HT receptor antagonists on the performance of rats in
attentional and working memory tasks. Eur Neuropsychopharmacol 7:99-108.
Scheneider S, Roessli D, Excoffier L. 2000. Arlequin ver.2.000. A software for population
genetics data analysis. University of Geneva.
Seeger G, Schloss P, Schmidt MH. 2001. Functional polymorphism within the promoter of
the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol
Psychiatry 6:235-238.
Spivak B, Vered Y, Yoran-Hegesh R, Averbuch E, Mester R, Graf E, Weizman A. 1999.
Circulatory levels of catecholamines, serotonin and lipids in attention deficit
hyperactivity disorder. Acta Psychiatr Scand 99:300-304.
Spurlock G, Heils A, Holmans P, Williams J, D’Souza UM, Cardno A et al. 1998. A
family based association study of T102C polymorphism in 5HT2A and schizophrenia
plus identification of new polymorphisms in the promoter. Mol Psychiatry 3:42-49.
Sumner BEH and Fink G. 1998. Testosterone as well as estrogen increases serotonin
2A
receptor mRNA and binding site densities in the male rat brain. Molecular Brain
Research 59:205-214.
Terwilliger J, Ott J. 1992. A haplotype-based “haplotype relative risk” approach to
detecting allelic associations. Hum Hered 42:337-346.
Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms M, Kuhn CM,
Lewis JG, et al. 2003. Serotonin-Related Gene Polymorphisms and central nervous
system serotonin function. Neuropsychopharmacology 28:533-541.
Xu X, Mill J, Chen CK, Brookes K, Taylor E, Asherson P. 2005. Family-based association
study of serotonin transporter gene polymorphisms in attention deficit hyperactivity
disorder. No evidence for association in UK and Taiwanese samples. Am J Med Genet
B Neuropsychiatr Genet [Epub ahead of print].
Zhang L, Ma W, Barker JL, Rubinow DR. 1999. Sex differences in expression of serotonin
receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone.
Neuroscience 94:251-259.
Zoroglu SS, Erdal ME, Erdal N, Ozen S, Alasehirli B, Sivasli E. 2003. No evidence for
association between the T102C and 1438 G/A polymorphisms of the serotonin receptor
34